Correlation Engine 2.0
Clear Search sequence regions


  • bms754807 (1)
  • breast cancer (2)
  • cell cycle (1)
  • IGF1 (6)
  • IGF1R (5)
  • micrornas (3)
  • miR 15b (7)
  • mTOR (1)
  • serum (1)
  • sv40 t- antigen (4)
  • targets genes (1)
  • weight (1)
  • Sizes of these terms reflect their relevance to your search.

    Calorie restriction (CR) inhibits triple-negative breast cancer (TNBC) progression in several preclinical models in association with decreased insulin-like growth factor 1 (IGF1) signaling. To investigate the impact of CR on microRNAs (miRs) that target the IGF1/IGF1R pathway, we used the spontaneous murine model of TNBC, C3(1)/SV40 T-antigen (C3-TAg). In C3-TAg mice, CR reduced body weight, IGF1 levels, and TNBC progression. We evaluated the tumoral expression of 10 miRs. CR increased the expression of miR-199a-3p, miR-199a-5p, miR-486, and miR-15b. However, only miR-15b expression correlated with tumorigenicity in the M28, M6, and M6C C3-TAg cell lines of TNBC progression. Overexpressing miR-15b reduced the proliferation of mouse (M6) and human (MDA-MB-231) cell lines. Serum restriction alone or in combination with low levels of recombinant IGF1 significantly upregulated miR-15b expression and reduced Igf1r in M6 cells. These effects were reversed by the pharmacological inhibition of IGFR with BMS754807. In silico analysis using miR web tools predicted that miR-15b targets genes associated with IGF1/mTOR pathways and the cell cycle. Our findings suggest that CR in association with reduced IGF1 levels could upregulate miR-15b to downregulate Igf1r and contribute to the anticancer effects of CR. Thus, miR-15b may be a therapeutic target for mimicking the beneficial effects of CR against TNBC.

    Citation

    Ximena Bustamante-Marin, Kaylyn L Devlin, Shannon B McDonell, Om Dave, Jenna L Merlino, Emma J Grindstaff, Alyssa N Ho, Erika T Rezeli, Michael F Coleman, Stephen D Hursting. Regulation of IGF1R by MicroRNA-15b Contributes to the Anticancer Effects of Calorie Restriction in a Murine C3-TAg Model of Triple-Negative Breast Cancer. Cancers. 2023 Aug 29;15(17)


    PMID: 37686596

    View Full Text